(Q37349822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Interference of pollutants with PPARs: endocrine disruption meets metabolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author

Cristina Casals Casas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Béatrice Desvergne

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

J N Feige

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

32 Suppl 6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

S53-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19079281%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2008.207

18 January 2020

exact match

0 references

cites work

Endocrine disrupters: a human risk?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

New modes of action for endocrine-disrupting chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Endocrine disruptors: from Wingspread to environmental developmental biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

The different effects of endocrine-disrupting chemicals on estrogen receptor-mediated transcription through interaction with coactivator TRAP220 in uterine tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Endocrine-disrupting chemicals use distinct mechanisms of action to modulate endocrine system function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Endocrine disruptors and the obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Chemical toxins: a hypothesis to explain the global obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Effects of endocrine disruptors on obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Childhood obesity is associated with maternal smoking in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Fetal origins of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Developmental exposure to estrogenic compounds and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Perinatal exposure to environmental estrogens and the development of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Metabolism of phthalates in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Phthalates: toxicology and exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Nuclear receptors and susceptibility to chemical exposure in aquatic organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Mechanism of thyroid hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Ligands have various potential effects on the degradation of pregnane X receptor by proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Epigenetic transgenerational actions of endocrine disruptors and male fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Peroxisome proliferator-activated receptors, coactivators, and downstream targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

PPARgamma, the ultimate thrifty gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Peroxisome proliferator-activated receptors: insight into multiple cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Activation of PPARalpha and PPARgamma by environmental phthalate monoesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

The pesticide adjuvant, Toximul, alters hepatic metabolism through effects on downstream targets of PPARalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Molecular basis of selective PPARgamma modulation for the treatment of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Integrating nuclear receptor mobility in models of gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Imaging protein molecules using FRET and FLIM microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Imaging biochemistry inside cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

PPARs: therapeutic targets for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Cumulative effects of dibutyl phthalate and diethylhexyl phthalate on male rat reproductive tract development: altered fetal steroid hormones and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

Association with Coregulators Is the Major Determinant Governing Peroxisome Proliferator-activated Receptor Mobility in Living Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207

inferred from DOI database lookup

7 January 2021

based on heuristic

Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.207